Hiroshi Takayanagi

Active 1997–2025

131
Papers
36,061
Citations
90
h-index
124
i10-index

Citations

Citations per year for Hiroshi Takayanagi1980: 7 citations1986: 1 citations1999: 3 citations2000: 19 citations2001: 48 citations2002: 70 citations2003: 103 citations2004: 119 citations2005: 238 citations2006: 218 citations2007: 256 citations2008: 324 citations2009: 386 citations2010: 290 citations2011: 310 citations2012: 443 citations2013: 371 citations2014: 330 citations2015: 363 citations2016: 285 citations2017: 372 citations2018: 414 citations2019: 1,262 citations2020: 1,514 citations2021: 1,357 citations2022: 1,196 citations2023: 930 citations2024: 1,393 citations2025: 750 citations2026: 25 citations1981–1985: no citations, so these years are not shown1987–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,834 citing papers, 23.6% of this breakdownChina: 2,506 citing papers, 20.9% of this breakdownJapan: 1,048 citing papers, 8.7% of this breakdownGermany: 586 citing papers, 4.9% of this breakdownUnited Kingdom: 572 citing papers, 4.8% of this breakdownAustralia: 392 citing papers, 3.3% of this breakdownSouth Korea: 366 citing papers, 3% of this breakdownItaly: 341 citing papers, 2.8% of this breakdownFrance: 308 citing papers, 2.6% of this breakdownCanada: 278 citing papers, 2.3% of this breakdownNetherlands: 217 citing papers, 1.8% of this breakdownSwitzerland: 163 citing papers, 1.3% of this breakdown
0%23.6%Other 20%

Fields

  • Biochemistry, Genetics and Molecular Biology42.2%
  • Medicine28.3%
  • Immunology and Microbiology18.1%
  • Neuroscience3.2%
  • Dentistry3.1%
  • Engineering2.6%
  • Other2.5%

Topics

  • Bone Metabolism and Diseases12%
  • Bone health and treatments5.4%
  • Immune Cell Function and Interaction3.2%
  • Bone health and osteoporosis research3.1%
  • T-cell and B-cell Immunology3.1%
  • Immune Response and Inflammation2.3%
  • Other70.9%

Coauthors

All papers

Open in search
  1. Mechanisms of joint destruction in rheumatoid arthritis — immune cell–fibroblast–bone interactions

    Authors: , - Nature Reviews Rheumatology 2022 cited by 497

  2. Osteoimmunology: evolving concepts in bone–immune interactions in health and disease

    Authors: , - Nature reviews. Immunology 2019 cited by 753

  3. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis

    Authors: , , , , , , , , - Nature Medicine 2013 cited by 1,128

  4. Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems

    Authors: , , , , , , , , - Physiological Reviews 2017 cited by 517

  5. Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

    Authors: , , , , , , , , , , , , , - Developmental Cell 2002 cited by 2,679

  6. Evidence for osteocyte regulation of bone homeostasis through RANKL expression

    Authors: , , , , , , , , , , , - Nature Medicine 2011 cited by 1,747

  7. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

    Authors: - Nature reviews. Immunology 2007 cited by 1,832

  8. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - EBioMedicine 2020 cited by 189

  9. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

    Authors: , , , , , , , , , , , - The Journal of Cell Biology 2006 cited by 1,525

  10. The molecular understanding of osteoclast differentiation

    Authors: , - Bone 2006 cited by 1,384

  11. Host defense against oral microbiota by bone-damaging T cells

    Authors: , , , , , , , , , - Nature Communications 2018 cited by 315

  12. Osteoprotection by semaphorin 3A

    Authors: , , , , , - Nature 2012 cited by 600

  13. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

    Authors: , , , , , , , , , , , - Nature 2000 cited by 1,363

  14. Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2007 cited by 1,008

  15. The Mechanisms of T Cell Selection in the Thymus

    Authors: , - Trends in Immunology 2017 cited by 276

  16. Endoplasmic reticulum mediates mitochondrial transfer within the osteocyte dendritic network

    Authors: , , , , , , , , , , , , , , , - Science Advances 2019 cited by 109

  17. Fezf2 Orchestrates a Thymic Program of Self-Antigen Expression for Immune Tolerance

    Authors: , , , , , , , - Cell 2015 cited by 384

  18. Suppression of bone formation by osteoclastic expression of semaphorin 4D

    Authors: , , , , , , - Nature Medicine 2011 cited by 495

  19. IL-17-producing γδ T cells enhance bone regeneration

    Authors: , , , , , , - Nature Communications 2016 cited by 360

  20. RANKL as the master regulator of osteoclast differentiation

    Authors: - Journal of Bone and Mineral Metabolism 2021 cited by 167

  21. Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution

    Authors: , , , , , , , , , , , , , , , , , - Nature Metabolism 2020 cited by 136

  22. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 848

  23. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2015 cited by 228

  24. Osteoimmunology

    Authors: , - Cold Spring Harbor Perspectives in Medicine 2018 cited by 137